HOME › DRUGS › INSULIN ICODEC;SEMAGLUTIDE
ACTIVE SUBSTANCE / INN

INSULIN ICODEC;SEMAGLUTIDE

Brand name(s): Kyinsu
EMA LISTED
AUTHORISED
Diabetes Mellitus, Type 2
ACTIVE SUBSTANCE
Insulin Icodec;Semaglutide
REGULATORS
EMA
SPONSORS / MAH
Novo Nordisk A/S
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
KyinsuNovo Nordisk A/SAuthorised24/11/2025Diabetes Mellitus, Type 2

FULL INTELLIGENCE ON INSULIN ICODEC;SEMAGLUTIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →